← FDA DRUG APPROVALS

FDA ANDA · ANDA077359

ZOLPIDEM TARTRATE

Sponsor: SUN PHARM INDS INC

APPLICATION
ANDA077359
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-23
LATEST ACTION
2020-11-24
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 10MG · TABLET · ORAL
ZOLPIDEM TARTRATEDiscontinued
ZOLPIDEM TARTRATE 5MG · TABLET · ORAL

Approval history

2020-11-24Labeling · Supplement 10 · standardAP
2020-11-24Labeling · Supplement 9 · standardAP
2008-10-14Labeling · Supplement 2AP
2007-04-23OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →